A Phase I/IIa Trial of Intravenous Immunoglobulin Following Portoenterostomy in Biliary Atresia

OBJECTIVES. Biliary atresia (BA) is a progressive neonatal fibroinflammatory cholangiopathy. We hypothesized that intravenous immunoglobulin (IVIg) would be safe, feasible, acceptable and efficacious for the treatment of BA. The primary objective of this study was to establish the feasibility, accep...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pediatr Gastroenterol Nutr
Hlavní autoři: Mack, Cara L., Spino, Cathie, Alonso, Estella M., Bezerra, Jorge A., Moore, Jeffrey, Goodhue, Catherine, Ng, Vicky L., Karpen, Saul J., Venkat, Veena, Loomes, Kathleen M., Wang, Kasper, Sherker, Averell H., Magee, John C., Sokol, Ronald J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6428610/
https://ncbi.nlm.nih.gov/pubmed/30664564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPG.0000000000002256
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky